Lipid-based slow-release formulation of amikacin sulfate reduces foreign body-associated infections in mice.

Treatment and prophylaxis of uncomplicated infections with standard systemic antibiotics are usually successful. However, standard systemic antibiotic therapy alone is frequently unsatisfactory in certain circumstances, such as the presence of a foreign body (FB), necrotic tissue, overwhelming bacte...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	Antimicrob Agents Chemother
Egile Nagusiak:	Roehrborn, A A, Hansbrough, J F, Gualdoni, B, Kim, S
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1995
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162821/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7486914/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.8.1752
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!